Search Immortality Topics:



Addex Therapeutics Completes Patient Enrollment for Dipraglurant Blepharospasm Phase 2 Clinical Study

Posted: April 13, 2022 at 1:50 am

Top-line Data Scheduled to Report in Q2 2022

Continue reading here:
Addex Therapeutics Completes Patient Enrollment for Dipraglurant Blepharospasm Phase 2 Clinical Study

Recommendation and review posted by Fredricko